Type 1 diabetes mellitus manifested in higher age, so called lada diabetes

Diabetologie Metabolismus Endokrinologie Vyziva

Volumn 4, Issue 3, 2001, Pages 158-171

  Anděl, Michal ^a   Novák, Jan ^a   Kučera, Petr ^a   Březina, Jiří ^a   Romanová, Hana ^a   Richterová, Anna ^a   Psottová, Jana ^a   Kadlec, Milan ^a   Vícha, Theodor ^a   Trešlová, Ludmila ^a   Perušičová, Jindřiška ^a   Potočková, Jana ^a  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

Author keywords

Diabetes; Diagnostics; LADA; Therapy

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; INSULIN; PROTEIN TYROSINE PHOSPHATASE; SULFONYLUREA;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; AUTOIMMUNE DISEASE; CELL FUNCTION; CHILD; CLINICAL FEATURE; DIET THERAPY; HUMAN; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MEDICAL RESEARCH; OBESITY; PANCREAS ISLET BETA CELL; VASCULAR DISEASE;

EID: 0035734578     PISSN: 12119326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Cardiovascular risk factors in Type 1 Diabetic Patients with Manifestation after 35 Years of Age
2. The Differences between Type 2 and LADA (Type 1) Diabetic Patients of Same Age
3. typu ve vyšším věku
4. LADA type of diabetes among Prague urban unselected diabetic patients
5. The pathogenesis of insulin - Dependent diabetes mellitus
6. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA - Synthesizing enzyme glutamic acid decarboxylase
7. Pancreas Extracts in the Treatment of Diabetes Mellitus
8. Diabetes mellitus
9. Glutamate decarboxylase: An autoantigen in IDDM
10. In American Diabetes Association: Clinical Practice Recommendations 2001
11. Diabetes Mellitus
12. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies
13. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults
14. Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis
15. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 65K auto-antitibody positivity at onset predicts diabetes type
16. Classification of diabetes melli tus and other categories of glucose intolerance
17. The Epidemiology of Diabetes Mellitus
18. A comparison of childhood and adult type I diabetes mellitus
19. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus
20. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease
21. Stanovení protilátek proti glutamát dekarboxylase v periferní krvi metodou ELISA
22. Autoimunita a protilátky proti glutamátdekarboxyláze v patogenezi diabetes mellitus I. typu v experimentu a klinické praxi
23. Contribution to the microscopic anatomy of the pancreas
24. How many people in the U.S. have IDDM?
25. Middle - Aged onset type 1 diabetes: Differences among individuals with and without autoimmune thyreoiditis
26. Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark
27. Predicting IDDM: Use of humeral immune markers
28. HLA - A, -B, nad - DR associations in type I diabetes mellitus with onset after age forty
29. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus
30. The Diabetes Prevetion Trial - Type 1 Diabetes (DPT - 1)design and implmentation of the oral antigen (insulin) protocol
31. GAD autoantibodies in a selection - Free population of insulin - Treated diabetic patients: Indicator of high prevalence of LADA?
32. Prevalence and incidence of insulin-treated diabetes mellitus in adults in Canterbury, New Zealand
33. Antibodies to glutamic acid decarboxylase (GAD) predict insulin deficiency in adult onset diabetes mellitus
34. Immune intervention in type I. diabetes mellitus
35. Die Bedeutung der Langerhanschen Inseln im Pankreas
36. Zur normalen und pathologischen Morphologie der inneren Sekretion der Bauchspeicheldrüse
37. Predicting insulin-dependent diabetes
38. Mild familial diabetes with dominant inheritance
39. Antibodies toglumatic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease
40. Persisting antibodies toGAD in IDDM are not associated with neuropathy
41. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before the clinical onset of the disease
42. UKPDS2 Autoantibodies to islet - Cell cytoplasm and glutamic acid decarboxylase for prediction of insulin rfequirement in type 2 diabetes
43. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: A population-based study
44. Type 1 diabetes in insulin - Treated adult - Onset diabetic subjects
45. Antibodies to glutamic acid decarboxylase (GAD) in Chinese IDDM patients
46. The ethnic distribution of antibodies to glutamic acid decarboxylase: Presence and levels in insulin-dependent diabetes mellitus in Europid and Asian subjects
47. Autoantibodies to glutamic acid decarboxylase and insulin in presymptomatic insulin-dependent diabetes mellitus: Frequency and segregation by age and gender
48. Latent autoimmune diabetes mellitus in adults (LADA) - The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency
49. Antibodies to glutamic acid decarboxylase and diabetes mellitus in multiple risk factor intervention trial
50. The pathogenesis and prevention of diabetes in adults: Genes, autoimmunity and demography
51. Crucial Points at Diagnosis. Type 2 diabetes or slow type 1 diabetes